NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted 23andMe authorization to sell tests for 33 pharmacogenetic variants directly to consumers.

The reports, the FDA said, provide consumers information about genetic variants that may be associated with their ability to metabolize some medications and help inform discussions with their healthcare providers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.